Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor Natural Killer Cell Therapy in Acute Myeloid Leukemia

被引：3
|
作者：
Tang, Thao T. [1 ]
Call, Lindsey F. [1 ]
Castro, Sommer [1 ]
Nourigat-Mckay, Cynthia [1 ]
Perkins, LaKeisha [1 ]
Pardo, Laura [2 ]
Leonti, Amanda R. [1 ]
Meshinchi, Soheil [1 ,3 ,4 ]
Le, Quy [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA USA
[2] Hematol Inc, Seattle, WA USA
[3] Univ Washington, Dept Pediat, Seattle, WA USA
[4] Childrens Oncol Grp, Monrovia, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-153156
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1712
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Anti-CD33 Chimeric Antigen Receptor Therapy For Acute Myeloid Leukemia
    O'Hear, Carol E.
    Heiber, Joshua
    Geiger, Terrence L.
    BLOOD, 2013, 122 (21)
  • [42] A Phase 1 Study of NKX101, a Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Therapy, with Fludarabine and Cytarabine in Patients with Acute Myeloid Leukemia
    Sauter, Craig S.
    Borthakur, Gautam
    Mountjoy, Luke
    Rotta, Marcello
    Liu, Hongtao
    Murthy, Hemant S.
    Lin, Ming
    Trager, James
    Chang, Cornell
    Kothari, Nishi
    Shook, David
    Bachier, Carlos
    BLOOD, 2023, 142
  • [43] Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells
    Reighard, Seth D.
    Cranert, Stacey A.
    Rangel, Kelly M.
    Ali, Ayad
    Gyurova, Ivayla E.
    de la Cruz-Lynch, Arthur T.
    Tuazon, Jasmine A.
    Khodoun, Marat, V
    Kottyan, Leah C.
    Smith, David F.
    Brunner, Hermine, I
    Waggoner, Stephen N.
    CELL REPORTS MEDICINE, 2020, 1 (01)
  • [44] Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia
    Yu, Wei
    Zhang, Hang
    Yuan, Yuncang
    Tang, Jie
    Chen, Xinchuan
    Liu, Ting
    Zhao, Xudong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [45] Chimeric Antigen Receptor (CAR) T Cell Therapy for CD7-Positive Acute Myeloid Leukemia
    Gomes-Silva, Diogo
    Tashiro, Haruko
    Srinivasan, Madhuwanti
    Lulla, Premal
    Brenner, Malcolm K.
    Mamonkin, Maksim
    BLOOD, 2017, 130
  • [46] Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances
    Canichella, Martina
    Molica, Matteo
    Mazzone, Carla
    de Fabritiis, Paolo
    Recher, Christian
    CANCERS, 2024, 16 (01)
  • [47] Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells
    Lynn, Rachel C.
    Poussin, Mathilde
    Kalota, Anna
    Feng, Yang
    Low, Philip S.
    Dimitrov, Dimiter S.
    Powell, Daniel J., Jr.
    BLOOD, 2015, 125 (22) : 3466 - 3476
  • [48] Evolution of natural killer cell-targeted therapy for acute myeloid leukemia
    Kaito, Yuta
    Imai, Yoichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 34 - 43
  • [49] Myeloid/natural killer cell acute leukemia.
    Hashimoto, CH
    Etzler, CM
    Peter, JB
    BLOOD, 1999, 94 (10) : 205B - 205B
  • [50] Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor
    Tettamanti, Sarah
    Marin, Virna
    Pizzitola, Irene
    Magnani, Chiara Francesca
    Attianese, Greta Maria Paola Giordano
    Cribioli, Elisabetta
    Lopez, Angel
    Biondi, Andrea
    Bonnet, Dominique
    Biagi, Ettore
    BLOOD, 2012, 120 (21)
12345